PACIFIC BIOSCIENCES CALIF IN's ticker is PACB and the CUSIP is 69404D108. A total of 97 filers reported holding PACIFIC BIOSCIENCES CALIF IN in Q3 2017. The put-call ratio across all filers is 6.74 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $508,000 | -28.2% | 19,896 | -1.7% | 0.00% | 0.0% |
| Q2 2021 | $708,000 | +4.7% | 20,237 | -0.3% | 0.00% | -25.0% |
| Q1 2021 | $676,000 | -41.4% | 20,306 | -54.3% | 0.00% | -33.3% |
| Q4 2020 | $1,153,000 | +4913.0% | 44,431 | +413.1% | 0.01% | – |
| Q4 2017 | $23,000 | -81.0% | 8,659 | -62.4% | 0.00% | -100.0% |
| Q3 2017 | $121,000 | -97.0% | 23,031 | -98.0% | 0.00% | -96.7% |
| Q2 2017 | $4,057,000 | -78.3% | 1,139,583 | -68.5% | 0.06% | -81.0% |
| Q1 2017 | $18,710,000 | +313.9% | 3,618,977 | +204.3% | 0.32% | +255.1% |
| Q4 2016 | $4,520,000 | -84.4% | 1,189,449 | -63.2% | 0.09% | -82.1% |
| Q3 2016 | $28,994,000 | +29.9% | 3,235,946 | +2.0% | 0.50% | +12.4% |
| Q2 2016 | $22,312,000 | -18.4% | 3,171,538 | -1.4% | 0.44% | -17.5% |
| Q1 2016 | $27,352,000 | -36.5% | 3,217,858 | -2.0% | 0.54% | -22.5% |
| Q4 2015 | $43,105,000 | – | 3,282,966 | – | 0.69% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ORACLE INVESTMENT MANAGEMENT INC | 1,446,459 | $48,182,000 | 7.22% |
| BOURNE LENT ASSET MANAGEMENT INC | 536,800 | $17,881,000 | 5.70% |
| Casdin Capital, LLC | 5,000,000 | $166,550,000 | 4.96% |
| Iron Triangle Partners LP | 935,805 | $31,172,000 | 3.96% |
| Jackson Square Partners, LLC | 12,911,695 | $430,088,000 | 2.44% |
| SB Management Ltd | 9,861,089 | $328,473,000 | 2.12% |
| Abacus Planning Group, Inc. | 180,000 | $5,996,000 | 1.92% |
| BERKSHIRE CAPITAL HOLDINGS INC | 413,800 | $13,784,000 | 1.57% |
| ARK Investment Management | 21,301,191 | $709,543,000 | 1.41% |
| Nikko Asset Management Americas, Inc. | 5,247,237 | $174,785,000 | 0.86% |